Benzylidene analogs of anabaseine display partial agonist and antagonist properties at the mouse 5-hydroxytryptamine3A receptor

Journal of Pharmacology and Experimental Therapeutics

Volumn 299, Issue 3, 2001, Pages 1112-1119

  Machu, Tina K ^a   Hamilton, Margaret E ^a   Frye, Tonia F ^a   Shanklin, Christopher L ^a   Harris, Michael C ^a   Sun, Hongwei ^a   Tenner Jr , Thomas E ^a   Soti, Ferenc S ^b   Kem, William R ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2 HYDROXY,4 METHOXY BENZYLIDENE)ANABASEINE; 3 (2 HYDROXYBENZYLIDENE)ANABASEINE; 3 (2,4 DIHYDROXYBENZYLIDENE)ANABASEINE; 3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; 3 (3 HYDROXYBENZYLIDENE)ANABASEINE; 3 (4 HYDROXYBENZYLIDENE)ANABASEINE; ANABASEINE; BENZYLIDENE DERIVATIVE; DRUG METABOLITE; NICOTINIC AGENT; PARTIAL AGONIST; PYRIDINE DERIVATIVE; SEROTONIN; SEROTONIN 3 AGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; SEROTONIN 3A AGONIST; SEROTONIN 3A ANTAGONIST; SEROTONIN 3A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DRUG EFFICACY; DRUG POTENCY; DRUG STRUCTURE; ELECTROPHYSIOLOGY; IC 50; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VOLTAGE CLAMP; XENOPUS LAEVIS;

ANABASINE; ANIMALS; BENZYLIDENE COMPOUNDS; BINDING SITES; ELECTROPHYSIOLOGY; NICOTINIC AGONISTS; OOCYTES; PYRIDINES; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; XENOPUS LAEVIS;

EID: 0035192882     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Agonist self-inhibitory site of the nicotinic acetylcholine receptor
2. Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors
3. Cloning and functional expression of a human 5-hydroxytryptamine type 3As receptor subunit
4. 3 receptor by bisindolylmaleimide I, a "selective" protein kinase C inhibitor
5. Enhancement by 5-hydroxytryptamine and analogues of desensitization of neuronal and muscle nicotinic receptors expressed in Xenopus oocytes
6. 3B subunit is a major determinant of serotonin-receptor function
7. 125I]α-bungarotoxin receptor subtypes
8. The effect of ondansetron on cognitive performance in the marmoset
9. Acetylcholine binding by a synthetic receptor: Implications for biological recognition
10. 3 receptor antagonists. Clinical pharmacology and therapeutic applications
11. Nicotinic agonists competitively antagonize serotonin at mouse 5-HT3 receptors expressed in Xenopus oocytes
12. Mechanisms of block
13. 3A receptor subunits
14. 3 receptor channel
15. The brain α7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: Studies with DMXBA (GTS-21)
16. Two primary GTS-21 metabolites are potent partial agonists at alpha7 nicotinic receptors expressed in the Xenopus oocyte
17. Anabaseine is a potent agonist upon muscle and neuronal α-bugarotoxin sensitive nicotinic receptors
18. Phase I studies of GTS-21 to assess the safety, tolerability, PK, and effects on measures of cognitive function in normal volunteers
19. 3 receptors in NIE-115 neuroblastoma cells
20. 3 receptor cDNA and its splice variants from guinea pig
21. Trichloroethanol potentiation of 5-hydroxytryptamine3 receptor mediated ion current in nodose ganglion neurons from the adult rat
22. 3 receptors expressed in Xenopus oocytes
23. Pharmacokinetics and urinary excretion of DMXBA (GTS-21), a compound enhancing cognition
24. 3 receptor, a serotonin-gated ion channel
25. Analysis of 3-(4-hydroxy, 2-methoxybenzylidene)-anabaseine selectivity and activity at human and rat α-7 nicotinic receptors
26. Neuroprotective and memory-related actions of novel α-7 nicotinic agents with different mixed agonist/antagonist properties
27. 3 receptor: Heterogeneity in distribution and function among species
28. 3 receptors
29. 3 antagonists: Recent advances
30. Antagonism of 5-HT3 receptor-mediated currents in murine N1E-115 neuroblastoma cells by (+)-tubocurarine
31. Novel and selective partial agonists of 5-HT3 receptors. Synthesis and biological evaluation of piperazinopyridopyrrolopyrazines, piperazinopyrroloquinoxalines, and piperazinopyridopyrroloquinoxalines
32. An initial three-component pharmacophore for specific serotonin-3 receptor ligands
33. Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands
34. 3 receptor ligand binding domain
35. Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice
36. Characterization of interaction of 3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester with Torpedo californica nicotinic acetylcholine receptor and 5-hydroxytryptamine3 receptor
37. 3 receptor
38. 3 receptor